AVONEX
AVONEX
Approved
DIN Number
02269201
Drug Class
Human
Market Date
Dec 2, 2005
Company
HC
Biogen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02269201
AIG Number0131806004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L03AB07 INTERFERON BETA-1A
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification92:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
INTERFERON BETA-1AActive
Strength: 30 MCG / 0.5 ML
Monograph: INTERFERON BETA-1A